Seer (SEER) Free Cash Flow (2020 - 2026)
Seer (SEER) posted quarterly Free Cash Flow of -$15.4 million for Q1 2026, down 27.94% year-over-year from -$21.4 million in Q1 2025, and down 39.15% quarter-over-quarter from -$11.1 million in Q4 2025.
Seer (SEER) Free Cash Flow (2020 - 2026) Analysis & Trends
Seer's Free Cash Flow history runs 7 years deep, the most recent figure standing at -$15.4 million for Q1 2026.
- In Q1 2026, Free Cash Flow fell 27.94% year-over-year to -$15.4 million; the TTM figure through Mar 2026 stood at -$49.6 million (up 2.41% YoY), while the FY2025 annual figure was -$46.2 million, up 6.94% from the prior year.
- Free Cash Flow for Q1 2026 stood at -$15.4 million, down from -$11.1 million in the prior quarter.
- The five-year high for Free Cash Flow was -$7.8 million in Q3 2025, with the low at -$20.2 million in Q1 2022.
- The 5-year median for Free Cash Flow is -$13.8 million (2022), against an average of -$14.1 million.
- Peak annual rise in Free Cash Flow reached 51.9% in 2025, while the deepest fall reached 32.04% in 2025.
- Seer's Free Cash Flow stood at -$13.8 million in 2022, then decreased by 25.16% to -$17.2 million in 2023, then jumped by 36.69% to -$10.9 million in 2024, then decreased by 1.63% to -$11.1 million in 2025, then sank by 39.15% to -$15.4 million in 2026.
- Business Quant data shows SEER's Free Cash Flow at -$15.4 million in Q1 2026, -$11.1 million in Q4 2025, and -$7.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.01 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 572.80 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -389.61 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 437.80 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -2.33 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 477.44 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 292.04 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -95.09 Mn |
| 10 | Seer | 230.63 Mn | 230.63 Mn | 1.51 Mn | -9.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -9.58 Mn |
| Jun 30, 2026 | -9.58 Mn |
| Mar 31, 2026 | -15.44 Mn |
| Mar 31, 2026 | -15.44 Mn |
| Dec 31, 2025 | -11.10 Mn |
| Dec 31, 2025 | -11.10 Mn |
| Sep 30, 2025 | -7.85 Mn |
| Sep 30, 2025 | -7.85 Mn |
| Jun 30, 2025 | -15.23 Mn |
| Jun 30, 2025 | -15.23 Mn |
| Mar 31, 2025 | -12.07 Mn |
| Mar 31, 2025 | -12.07 Mn |
| Dec 31, 2024 | -10.92 Mn |
| Dec 31, 2024 | -10.92 Mn |
| Sep 30, 2024 | -16.32 Mn |
| Sep 30, 2024 | -16.32 Mn |
| Jun 30, 2024 | -11.53 Mn |
| Jun 30, 2024 | -11.53 Mn |
| Mar 31, 2024 | -10.92 Mn |
| Mar 31, 2024 | -10.92 Mn |